Matregenix
Publicly observedBoston, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Boston | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Matregenix | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | HHSXEWBABG23 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Sept 2026Publicly observed
NIH SBIR/STTR award: Sustained 9-cis Retinoic Acid-Eluting Nanofiber Scaffolds for Enhanced Lymphatic Regeneration and Lymphedema Treatment
USD 314,211.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2025Publicly observed
NIH SBIR/STTR award: Enhancing Dental and Craniomaxillofacial Surgery Outcomes with Cost-Effective and Scalable Animal-Free Amino Acid-Based Membranes for Guided Bone Regeneration
USD 1,119,000.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jul 2025Publicly observed
NIH SBIR/STTR award: Enhancing Dental and Craniomaxillofacial Surgery Outcomes with Cost-Effective and Scalable Animal-Free Amino Acid-Based Membranes for Guided Bone Regeneration
USD 976,000.00 · National Institute of Dental and Craniofacial Research · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.